Neurol India Close
 

Figure 1: (a) and (b) revealed heterogeneous contrast enhancement of the lobular tumor (c) Strong immunoreactivity for bcl-2 (400)

Figure 1: (a) and (b) revealed heterogeneous contrast enhancement of the lobular tumor (c) Strong immunoreactivity for bcl-2 (400)